Indo Us Biotech Limited — Others, 23-11-2024: Copy of Newspaper Publication

Indo US Biotech Limited has issued a corrigendum to its postal ballot notice, seeking shareholder approval to increase its authorized share capital from ₹21 crore to ₹31 crore. This adjustment involves a change from two crore equity shares to three crore ten lakh equity shares, each with a face value of ₹10. The ongoing e-voting, which commenced earlier, allows shareholders to modify their prior votes by the deadline. This update reflects the company's proactive governance approach aimed at enhancing financial flexibility, which may bolster investor confidence regarding its growth aspirations. Overall, this move signals a positive outlook for resource mobilization amidst ongoing expansion efforts.